Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis.

Justice AC, Modur SP, Tate JP, Althoff KN, Jacobson LP, Gebo KA, Kitahata MM, Horberg MA, Brooks JT, Buchacz K, Rourke SB, Rachlis A, Napravnik S, Eron J, Willig JH, Moore R, Kirk GD, Bosch R, Rodriguez B, Hogg RS, Thorne J, Goedert JJ, Klein M, Gill J, Deeks S, Sterling TR, Anastos K, Gange SJ; NA-ACCORD and VACS Project Teams.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):149-63. doi: 10.1097/QAI.0b013e31827df36c.

2.

An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Nattermann J, Lampe FC, Bucher HC, Sterling TR, Crane HM, Kitahata MM, May M, Sterne JA.

AIDS. 2013 Feb 20;27(4):563-72. doi: 10.1097/QAD.0b013e32835b8c7f.

3.

Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?

Justice AC, Freiberg MS, Tracy R, Kuller L, Tate JP, Goetz MB, Fiellin DA, Vanasse GJ, Butt AA, Rodriguez-Barradas MC, Gibert C, Oursler KA, Deeks SG, Bryant K; VACS Project Team.

Clin Infect Dis. 2012 Apr;54(7):984-94. doi: 10.1093/cid/cir989. Epub 2012 Feb 15.

4.

Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers.

Justice AC, McGinnis KA, Skanderson M, Chang CC, Gibert CL, Goetz MB, Rimland D, Rodriguez-Barradas MC, Oursler KK, Brown ST, Braithwaite RS, May M, Covinsky KE, Roberts MS, Fultz SL, Bryant KJ; VACS Project Team.

HIV Med. 2010 Feb;11(2):143-51. doi: 10.1111/j.1468-1293.2009.00757.x. Epub 2009 Sep 14.

5.

HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.

So-Armah KA, Chang J, Alcorn C, Lo Re V, Baker JV, Tracy R, Butt AA, Agan BK, Rimland D, Gibert CL, Goetz MB, Oursler KK, Rodriguez-Barradas MC, Kuller LH, Brown ST, Stein JH, Skanderson M, Justice AC, Freiberg MS.

Curr HIV Res. 2014;12(1):50-9.

6.

Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women.

Cohen MH, Hotton AL, Hershow RC, Levine A, Bacchetti P, Golub ET, Anastos K, Young M, Gustafson D, Weber KM.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):538-44. doi: 10.1097/QAI.0000000000000795.

7.

The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study.

Brown ST, Tate JP, Kyriakides TC, Kirkwood KA, Holodniy M, Goulet JL, Angus BJ, Cameron DW, Justice AC; OPTIMA Team.

PLoS One. 2014 Mar 25;9(3):e92606. doi: 10.1371/journal.pone.0092606. eCollection 2014.

8.

Baseline, Time-Updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.

Salinas JL, Rentsch C, Marconi VC, Tate J, Budoff M, Butt AA, Freiberg MS, Gibert CL, Goetz MB, Leaf D, Rodriguez-Barradas MC, Justice AC, Rimland D.

Clin Infect Dis. 2016 Dec 1;63(11):1423-1430. Epub 2016 Aug 18.

9.

Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.

May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).

Int J Epidemiol. 2012 Dec;41(6):1807-20. doi: 10.1093/ije/dys164. Epub 2012 Nov 12.

10.

Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.

May MT, Vehreschild JJ, Trickey A, Obel N, Reiss P, Bonnet F, Mary-Krause M, Samji H, Cavassini M, Gill MJ, Shepherd LC, Crane HM, d'Arminio Monforte A, Burkholder GA, Johnson MM, Sobrino-Vegas P, Domingo P, Zangerle R, Justice AC, Sterling TR, Miró JM, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC), Boulle A, Stephan C, Miro JM, Cavassini M, Chêne G, Costagliola D, Dabis F, Monforte AD, Del Amo J, Van Sighem A, Fätkenheuer G, Gill J, Guest J, Haerry DH, Hogg R, Justice A, Shepherd L, Obel N, Crane H, Smith C, Reiss P, Saag M, Sterling T, Teira R, Williams M, Zangerle R, Sterne J, May M, Ingle S, Trickey A.

Clin Infect Dis. 2016 Jun 15;62(12):1571-1577. doi: 10.1093/cid/ciw183. Epub 2016 Mar 29.

11.

Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.

De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AM, Buonomo E, Prosperi MC, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):236-44. doi: 10.1097/QAI.0b013e31824276e9.

PMID:
22327246
12.

Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.

Vinikoor MJ, Sinkala E, Mweemba A, Zanolini A, Mulenga L, Sikazwe I, Fried MW, Eron JJ, Wandeler G, Chi BH.

Liver Int. 2015 Jul;35(7):1886-92. doi: 10.1111/liv.12780. Epub 2015 Jan 22.

13.

Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.

Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM.

AIDS Patient Care STDS. 2012 Feb;26(2):73-80. doi: 10.1089/apc.2011.0191. Epub 2012 Jan 12.

14.

Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.

Marcus JL, Leyden WA, Chao CR, Xu L, Quesenberry CP Jr, Tien PC, Klein DB, Towner WJ, Horberg MA, Silverberg MJ.

AIDS Patient Care STDS. 2015 Jul;29(7):370-8. doi: 10.1089/apc.2015.0040. Epub 2015 May 18.

15.

The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment.

Marquine MJ, Umlauf A, Rooney AS, Fazeli PL, Gouaux BD, Paul Woods S, Letendre SL, Ellis RJ, Grant I, Moore DJ; HIV Neurobehavioral Research Program (HNRP) Group.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):190-7. doi: 10.1097/QAI.0000000000000008.

16.

Sex disparities in overall burden of disease among HIV-infected individuals in the Veterans Affairs healthcare system.

Blackstock OJ, Tate JP, Akgün KM, Crystal S, Duggal M, Edelman EJ, Gibert CL, Gordon KS, Rimland D, Rodriguez-Barradas MC, Wang EA, Fiellin DA, Justice AC.

J Gen Intern Med. 2013 Jul;28 Suppl 2:S577-82. doi: 10.1007/s11606-013-2346-z.

17.

Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era.

Akgün KM, Tate JP, Pisani M, Fried T, Butt AA, Gibert CL, Huang L, Rodriguez-Barradas MC, Rimland D, Justice AC, Crothers K.

Crit Care Med. 2013 Jun;41(6):1458-67. doi: 10.1097/CCM.0b013e31827caa46.

18.

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

Mendeni M, Focà E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C.

Clin Infect Dis. 2011 May;52(9):1164-73. doi: 10.1093/cid/cir071.

PMID:
21467023
19.

Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores.

Mooney S, Tracy R, Osler T, Grace C.

PLoS One. 2015 Dec 7;10(12):e0144312. doi: 10.1371/journal.pone.0144312. eCollection 2015.

20.

The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy.

Bebu I, Tate J, Rimland D, Mesner O, Macalino GE, Ganesan A, Okulicz JF, Bavaro M, Weintrob AC, Justice AC, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):226-30. doi: 10.1097/QAI.0000000000000045.

Supplemental Content

Support Center